SCYNEXIS INC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SCYNEXIS, Inc. on July 16, 2020. The report details a corporate action involving a reverse stock split and a reduction in authorized shares, effective July 17, 2020.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure adjustments rather than financial performance results.
Material Changes
- Reverse Stock Split: A 1-for-10 reverse stock split of common stock was implemented effective July 17, 2020. Every ten shares of issued and outstanding common stock were converted into one share.
- Authorized Shares Reduction: The number of authorized shares of common stock was decreased from 250,000,000 to 100,000,000 shares.
- Impact on Securities: The split affects shares available under equity incentive plans and reduces the number of shares issuable upon conversion of convertible notes or exercise of options and warrants.
- Fractional Shares: No fractional shares were issued; stockholders entitled to fractional shares received cash payments in lieu thereof.
- Trading Details: Common stock began trading on the Nasdaq Global Market on a split-adjusted basis on July 17, 2020, under the new CUSIP number 811292 200.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document is strictly a notification of the amendment to the Certificate of Incorporation.
Investor Verification Checklist
- Verify the new CUSIP number (811292 200) for trading purposes.
- Confirm the adjusted share count in brokerage accounts following the 1-for-10 split.
- Review the impact of the split on outstanding options, warrants, and convertible notes.
- Check for cash payments received in lieu of fractional shares.